{"ABMD": {"Ticker": "ABMD", "Company": "Abiomed", "Sector": "Health Care", "Updated": "2022-11-02", "Rating": [{"Date": "2022-11-02", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": "$235 to $380"}, {"Date": "2022-11-02", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$355 to $388"}, {"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$300"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Mizuho", "Morgan Stanley", "Deutsche Bank"], "Price_Target": 356.0}, "CTLT": {"Ticker": "CTLT", "Company": "Catalent", "Sector": "Health Care", "Updated": "2022-11-02", "Rating": [{"Date": "2022-11-02", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$125 to $60"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["BofA Securities"], "Price_Target": 60.0}, "ECL": {"Ticker": "ECL", "Company": "Ecolab", "Sector": "Materials", "Updated": "2022-11-02", "Rating": [{"Date": "2022-11-02", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$165 to $135"}, {"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "Seaport Research Partners", "Rating_Change": "Neutral to Buy", "Target_Change": "$190"}, {"Date": "2022-09-06", "Rating": "Upgrade", "Organization": "Northcoast", "Rating_Change": "Neutral to Buy", "Target_Change": "$188"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Seaport Research Partners", "Northcoast", "Deutsche Bank"], "Price_Target": 171.0}, "MSFT": {"Ticker": "MSFT", "Company": "Microsoft", "Sector": "Information Technology", "Updated": "2022-11-02", "Rating": [{"Date": "2022-11-02", "Rating": "Initiated", "Organization": "Macquarie", "Rating_Change": "Neutral", "Target_Change": "$234"}, {"Date": "2022-10-14", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$354 to $325"}, {"Date": "2022-09-30", "Rating": "Resumed", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$300"}, {"Date": "2022-09-22", "Rating": "Initiated", "Organization": "MoffettNathanson", "Rating_Change": "Hold", "Target_Change": "$285"}, {"Date": "2022-08-12", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Neutral", "Target_Change": "$292"}], "Score": 0.8, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Guggenheim", "MoffettNathanson", "Raymond James", "Macquarie", "Morgan Stanley"], "Price_Target": 287.2}, "NDAQ": {"Ticker": "NDAQ", "Company": "Nasdaq", "Sector": "Financials", "Updated": "2022-11-02", "Rating": [{"Date": "2022-11-02", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$66 to $57"}, {"Date": "2022-10-14", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Underperform", "Target_Change": "$65 to $58"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$62"}, {"Date": "2022-10-06", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$70"}, {"Date": "2022-08-19", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$190 to $200"}, {"Date": "2022-08-17", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Buy", "Target_Change": "$241"}], "Score": -0.17, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "C", "Analists": ["JP Morgan", "Citigroup", "Credit Suisse", "Rosenblatt", "Atlantic Equities", "BofA Securities"], "Price_Target": 114.67}, "CRM": {"Ticker": "CRM", "Company": "Salesforce", "Sector": "Information Technology", "Updated": "2022-11-02", "Rating": [{"Date": "2022-11-02", "Rating": "Resumed", "Organization": "Macquarie", "Rating_Change": "Outperform", "Target_Change": "$210"}, {"Date": "2022-10-17", "Rating": "Initiated", "Organization": "Northland Capital", "Rating_Change": "Market Perform", "Target_Change": "$150"}, {"Date": "2022-09-28", "Rating": "Downgrade", "Organization": "Cleveland Research", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-09-02", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Sell to Neutral", "Target_Change": "$150"}, {"Date": "2022-08-12", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Sell", "Target_Change": "$150"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Guggenheim", "Northland Capital", "Macquarie", "Cleveland Research"], "Price_Target": 165.0}, "NOW": {"Ticker": "NOW", "Company": "ServiceNow", "Sector": "Information Technology", "Updated": "2022-11-02", "Rating": [{"Date": "2022-11-02", "Rating": "Resumed", "Organization": "Macquarie", "Rating_Change": "Outperform", "Target_Change": "$500"}, {"Date": "2022-10-31", "Rating": "Initiated", "Organization": "CapitalOne", "Rating_Change": "Overweight", "Target_Change": "$516"}, {"Date": "2022-10-27", "Rating": "Upgrade", "Organization": "MoffettNathanson", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$549"}, {"Date": "2022-10-24", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2022-10-11", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$460"}, {"Date": "2022-09-22", "Rating": "Initiated", "Organization": "MoffettNathanson", "Rating_Change": "Hold", "Target_Change": "$553"}, {"Date": "2022-08-12", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Neutral", "Target_Change": "$510"}], "Score": 1.43, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 7, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Guggenheim", "JP Morgan", "MoffettNathanson", "Macquarie", "CapitalOne"], "Price_Target": 514.67}}